SCHEMBL30337202

SCHEMBL30337202

Cc1c(-c2ccnc(Cl)n2)c2ccccc2n1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
HPGD P15428 3/20 0.39
GPR3 P46089 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KDR P35968 2/20 0.38
PTK2 Q05397 2/20 0.38
AKT1 P31749 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
RPS6KA5 O75582 1/20 0.37
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
MAPK14 Q16539 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17822333 1.00 ALDH1A1 (0.39) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30337358 0.83 GAA (0.40) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL28987638 0.83 GAA (0.40) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL30337199 0.82 TEK (0.46) ALDH1A1KMT2AHPGDCYP2C19HTT
SCHEMBL17384806 0.82 TEK (0.46) ALDH1A1KMT2AHPGDCYP2C19HTT
SCHEMBL19103283 0.81 EGFR (0.41) ALDH1A1MEN1KMT2AGPR3GLA
SCHEMBL19103280 0.77 KDM4E (0.47) ALDH1A1KDM4EKMT2AHPGDHSD17B10
SCHEMBL31105657 0.77 KDM4E (0.47) ALDH1A1KDM4EKMT2AHPGDHSD17B10
SCHEMBL21165735 0.77 KMT2A (0.40) KDM4EKMT2AGAAHTTMAPT
SCHEMBL22619772 0.76 CHRM2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-112457298-B Substituted 2-anilinopyrimidine derivatives and their use as epidermal growth factor receptor modulators 贝达医药公司 2024-05-07 CN disclosed
CN-112375067-B Substituted 2-anilinopyrimidine derivatives and their use as epidermal growth factor receptor modulators 贝达医药公司 2024-03-15 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed